Case Report: Daily CBD Administration Associated With Remission Of Schizophrenic Symptoms

schizophrenic

GERMANY: The adjunctive use of cannabidiol is associated with a remission in schizophrenic symptoms in a patient previously unresponsive to conventional treatment, according to a case report published in the Australian & New Zealand Journal of Psychiatry. Investigators from the University of Leipzig in Germany assessed the use of twice-daily dosing of 750mg of CBD in conjunction with clozapine Read the full article…

Comparing Adverse Effects of Marijuana, Alcohol

“The paucity of research is of particular public health concern as alcohol and marijuana are the two most commonly used psychoactive substances among adolescents,” said Joseph J. Palamar, Ph.D., M.P.H.

NEW YORK: The emerging debate about whether marijuana is “safer” than other substances has led to a new study documenting how alcohol and marijuana use impacts the psychosocial well-being of high school seniors. Researchers affiliated with New York University published the study online ahead of print in the American Journal of Drug and Alcohol Abuse. Investigators analyzed Read the full article…

Forget Marijuana Madness: Could Marijuana Treat Your Depression

“THC administration reduces the negative bias in emotional processing,” said the researchers. “This adds human evidence to support the hypothesis that the endocannabinoid system is involved in the modulation of emotional processing.”

NETHERLANDS: Depending on who you listen to, marijuana could be the solution for whatever ails you or your ultimate demise; or it could make you dumb and sick. We have a tendency to believe the research not funded by biased parties in support of federal marijuana prohibition—the research that shows cannabis may reduce the risk of Alzheimer’s and obesity, Read the full article…